Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer.


Journal article


Kristina Golfmann, Lydia Meder, Mirjam Koker, Caroline Volz, Sven Borchmann, Lars Tharun, Felix Dietlein, Florian Malchers, Alexandra Florin, Reinhard Büttner, Neal Rosen, Vanessa Rodrik-Outmezguine, Michael Hallek, Roland T Ullrich
Oncogene, vol. 37(42), 2018 Jun 3, pp. 5682-5693

Cite

Cite

APA   Click to copy
Golfmann, K., Meder, L., Koker, M., Volz, C., Borchmann, S., Tharun, L., … Ullrich, R. T. (2018). Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer. Oncogene, 37(42), 5682–5693.


Chicago/Turabian   Click to copy
Golfmann, Kristina, Lydia Meder, Mirjam Koker, Caroline Volz, Sven Borchmann, Lars Tharun, Felix Dietlein, et al. “Synergistic Anti-Angiogenic Treatment Effects by Dual FGFR1 and VEGFR1 Inhibition in FGFR1-Amplified Breast Cancer.” Oncogene 37, no. 42 (June 3, 2018): 5682–5693.


MLA   Click to copy
Golfmann, Kristina, et al. “Synergistic Anti-Angiogenic Treatment Effects by Dual FGFR1 and VEGFR1 Inhibition in FGFR1-Amplified Breast Cancer.” Oncogene, vol. 37, no. 42, June 2018, pp. 5682–93.


BibTeX   Click to copy

@article{kristina2018a,
  title = {Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer.},
  year = {2018},
  month = jun,
  day = {3},
  issue = {42},
  journal = {Oncogene},
  pages = {5682-5693},
  volume = {37},
  author = {Golfmann, Kristina and Meder, Lydia and Koker, Mirjam and Volz, Caroline and Borchmann, Sven and Tharun, Lars and Dietlein, Felix and Malchers, Florian and Florin, Alexandra and Büttner, Reinhard and Rosen, Neal and Rodrik-Outmezguine, Vanessa and Hallek, Michael and Ullrich, Roland T},
  month_numeric = {6}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in